(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway

BACKGROUND: The aim of this study was to investigate the regulative activity of (5R)-5-hydroxytriptolide (LLDT-8) on receptor activator of nuclear factor κ-B ligand (RANKL)/receptor activator of nuclear factor κ-B (RANK)/Osteoprotegerin (OPG) system in rheumatoid arthritis (RA) and its anti-osteocla...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Complement Altern Med
Main Authors: Shen, Yi, Jiang, Ting, Wang, Rongsheng, He, Shijun, Guo, Mengru, Zuo, Jianping, He, Dongyi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379732/
https://ncbi.nlm.nih.gov/pubmed/25887296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-015-0566-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki